Cargando…
Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study
BACKGROUND: Neglected tropical diseases (NTDs) account for a large disease burden in sub-Saharan Africa. While the general cost-effectiveness of NTD interventions to improve health outcomes has been assessed, few studies have also accounted for the financial and education gains of investing in NTD c...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307713/ https://www.ncbi.nlm.nih.gov/pubmed/30589847 http://dx.doi.org/10.1371/journal.pntd.0007002 |
_version_ | 1783383050939269120 |
---|---|
author | De Neve, Jan-Walter Andriantavison, Rija L. Croke, Kevin Krisam, Johannes Rajoela, Voahirana H. Rakotoarivony, Rary A. Rambeloson, Valérie Schultz, Linda Qamruddin, Jumana Verguet, Stéphane |
author_facet | De Neve, Jan-Walter Andriantavison, Rija L. Croke, Kevin Krisam, Johannes Rajoela, Voahirana H. Rakotoarivony, Rary A. Rambeloson, Valérie Schultz, Linda Qamruddin, Jumana Verguet, Stéphane |
author_sort | De Neve, Jan-Walter |
collection | PubMed |
description | BACKGROUND: Neglected tropical diseases (NTDs) account for a large disease burden in sub-Saharan Africa. While the general cost-effectiveness of NTD interventions to improve health outcomes has been assessed, few studies have also accounted for the financial and education gains of investing in NTD control. METHODS: We built on extended cost-effectiveness analysis (ECEA) methods to assess the health gains (e.g. infections, disability-adjusted life years or DALYs averted), household financial gains (out-of-pocket expenditures averted), and education gains (cases of school absenteeism averted) for five NTD interventions that the government of Madagascar aims to roll out nationally. The five NTDs considered were schistosomiasis, lymphatic filariasis, and three soil-transmitted helminthiases (Ascaris lumbricoides, Trichuris trichiura, and hookworm infections). RESULTS: The estimated incremental cost-effectiveness for the roll-out of preventive chemotherapy for all NTDs jointly was USD125 per DALY averted (95% uncertainty range: 65–231), and its benefit-cost ratio could vary between 5 and 31. Our analysis estimated that, per dollar spent, schistosomiasis preventive chemotherapy, in particular, could avert a large number of infections (176,000 infections averted per $100,000 spent), DALYs (2,000 averted per $100,000 spent), and cases of school absenteeism (27,000 school years gained per $100,000 spent). CONCLUSION: This analysis incorporates financial and education gains into the economic evaluation of health interventions, and therefore provides information about the efficiency of attainment of three Sustainable Development Goals (SDGs). Our findings reveal how the national scale-up of NTD control in Madagascar can help address health (SDG3), economic (SDG1), and education (SDG4) goals. This study further highlights the potentially large societal benefits of investing in NTD control in low-resource settings. |
format | Online Article Text |
id | pubmed-6307713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-63077132019-01-08 Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study De Neve, Jan-Walter Andriantavison, Rija L. Croke, Kevin Krisam, Johannes Rajoela, Voahirana H. Rakotoarivony, Rary A. Rambeloson, Valérie Schultz, Linda Qamruddin, Jumana Verguet, Stéphane PLoS Negl Trop Dis Research Article BACKGROUND: Neglected tropical diseases (NTDs) account for a large disease burden in sub-Saharan Africa. While the general cost-effectiveness of NTD interventions to improve health outcomes has been assessed, few studies have also accounted for the financial and education gains of investing in NTD control. METHODS: We built on extended cost-effectiveness analysis (ECEA) methods to assess the health gains (e.g. infections, disability-adjusted life years or DALYs averted), household financial gains (out-of-pocket expenditures averted), and education gains (cases of school absenteeism averted) for five NTD interventions that the government of Madagascar aims to roll out nationally. The five NTDs considered were schistosomiasis, lymphatic filariasis, and three soil-transmitted helminthiases (Ascaris lumbricoides, Trichuris trichiura, and hookworm infections). RESULTS: The estimated incremental cost-effectiveness for the roll-out of preventive chemotherapy for all NTDs jointly was USD125 per DALY averted (95% uncertainty range: 65–231), and its benefit-cost ratio could vary between 5 and 31. Our analysis estimated that, per dollar spent, schistosomiasis preventive chemotherapy, in particular, could avert a large number of infections (176,000 infections averted per $100,000 spent), DALYs (2,000 averted per $100,000 spent), and cases of school absenteeism (27,000 school years gained per $100,000 spent). CONCLUSION: This analysis incorporates financial and education gains into the economic evaluation of health interventions, and therefore provides information about the efficiency of attainment of three Sustainable Development Goals (SDGs). Our findings reveal how the national scale-up of NTD control in Madagascar can help address health (SDG3), economic (SDG1), and education (SDG4) goals. This study further highlights the potentially large societal benefits of investing in NTD control in low-resource settings. Public Library of Science 2018-12-27 /pmc/articles/PMC6307713/ /pubmed/30589847 http://dx.doi.org/10.1371/journal.pntd.0007002 Text en © 2018 De Neve et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article De Neve, Jan-Walter Andriantavison, Rija L. Croke, Kevin Krisam, Johannes Rajoela, Voahirana H. Rakotoarivony, Rary A. Rambeloson, Valérie Schultz, Linda Qamruddin, Jumana Verguet, Stéphane Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study |
title | Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study |
title_full | Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study |
title_fullStr | Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study |
title_full_unstemmed | Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study |
title_short | Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study |
title_sort | health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in madagascar: a modeling study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307713/ https://www.ncbi.nlm.nih.gov/pubmed/30589847 http://dx.doi.org/10.1371/journal.pntd.0007002 |
work_keys_str_mv | AT denevejanwalter healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy AT andriantavisonrijal healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy AT crokekevin healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy AT krisamjohannes healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy AT rajoelavoahiranah healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy AT rakotoarivonyrarya healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy AT rambelosonvalerie healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy AT schultzlinda healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy AT qamruddinjumana healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy AT verguetstephane healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy |